Summary

Bristol-Myers Squibb Beats

Bristol-Myers Squibb (BMY) reported 1st Quarter March 2026 earnings of $1.58 per share on revenue of $11.5 billion. The consensus earnings estimate was $1.44 per share on revenue of $10.9 billion. The Earnings Whisper number was $1.48 per share. Revenue grew 2.6% on a year-over-year basis.

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Earnings Release

Bristol Myers Squibb Reports First Quarter Financial Results for 2026

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results.

Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed first quarter 2026 earnings press release and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, April 30, 2026, which is accessible here. Company executives will review financial results with the investment community during the call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20260430621474/en/

Media Relations: media@bms.com

Investor Relations: investor.relations@bms.com

Source: Bristol Myers Squibb